SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
Current Report Pursuant to Section 13 or
15(d) of the Securities Exchange Act of 1934
Date of Report (date of earliest event reported): November 1995
BIOPHARMACEUTICS, INC.
(Exact name of Registrant as specified in its Charter)
DELAWARE 1-9370 13-3186327
(State or other (Commission File Number) (I.R.S Employer
jurisdiction of I.D. Number)
incorporation)
990 Station Road
Bellport, New York 11713
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (516)286-5800
N/A
(Former name or former address, if changed since last report.)
1
<PAGE>
Item 5. Other Events
By court order dated November 1, 1995, the United States District Court
for the Eastern District of New York issued a preliminary injunction enjoining
Biopharmaceutics, Inc. and Biopharm Lab, Inc. from exploiting any licensed
rights in the "Treo" skin care product with respect to the 1996 selling season.
EXHIBIT INDEX
Current Report on Form 8-K
of
Biopharmaceutics, Inc.
Date of Report: November 13, 1995
Exhibits:
28.7 Court order dated November 1, 1995
2
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
BIOPHARMACEUTICS, INC.
(Registrant)
By: /s/ Edward Fine
---------------------
Edward Fine
President, Chief Executive Officer
(Signature)
Dated: November 13, 1995
3
<PAGE>
